Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial

Simple item page
dc.article.end-page14en
dc.article.start-page1en
dc.citation.doi10.1016/J.EBIOM.2022.104322en
dc.contributor.authorNomathemba Chandiwanaen
dc.contributor.authorC Krugeren
dc.contributor.authorH Johnstoneen
dc.contributor.authorM Chughlayen
dc.contributor.authorC Juen
dc.contributor.authorYengiwe Dinekaen
dc.contributor.authorE et alen
dc.contributor.authorWillem Venteren
dc.date.accessioned2024-05-08T10:38:02Z
dc.date.available2024-05-08T10:38:02Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2352-3964en
dc.identifier.urihttps://hdl.handle.net/10539/38431
dc.journal.titleSafety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialen
dc.journal.volume86en
dc.titleSafety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
533.9 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Wits Research Outputs